SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Characterisation of Invasive Streptococcus pneumoniae Isolated from Cambodian Children between 2007 - 2012.

Moore, CE; Giess, A; Soeng, S; Sar, P; Kumar, V; Nhoung, P; Bousfield, R; Turner, P; Stoesser, N; Day, NPJ; et al. Moore, CE; Giess, A; Soeng, S; Sar, P; Kumar, V; Nhoung, P; Bousfield, R; Turner, P; Stoesser, N; Day, NPJ; Parry, CM (2016) Characterisation of Invasive Streptococcus pneumoniae Isolated from Cambodian Children between 2007 - 2012. PLoS One, 11 (7). e0159358. ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0159358
SGUL Authors: Moore, Catrin Elisabeth

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (386kB) | Preview
[img] Microsoft Word (.docx) (S1 Table) Published Version
Available under License Creative Commons Attribution.

Download (46kB)

Abstract

BACKGROUND: The 13-valent pneumococcal vaccine (PCV13) was introduced in Cambodia in January 2015. There are limited data concerning the common serotypes causing invasive pneumococcal disease (IPD). Knowledge of the circulating pneumococcal serotypes is important to monitor epidemiological changes before and after vaccine implementation. METHODS: All episodes of IPD defined by the isolation of Streptococcus pneumoniae from blood, cerebrospinal fluid or other sterile site in Cambodian children admitted to the Angkor Hospital for Children in Siem Reap, Northwestern Cambodia, between 1st January 2007 and 1st July 2012 were retrospectively studied. Streptococcus pneumoniae isolates that could be retrieved underwent phenotypic typing and whole genome sequencing. RESULTS: There were 90 Cambodian children hospitalized with IPD with a median (IQR) age of 2.3 years (0.9-6.2). The case fatality was 15.6% (95% CI 8-23). Of 50 Streptococcus pneumoniae isolates available for further testing, 46% were penicillin non-susceptible and 8% were ceftriaxone non-susceptible, 78% were cotrimoxazole resistant, 30% were erythromycin resistant and 30% chloramphenicol resistant. There were no significant changes in resistance levels over the five-year period. The most common serotypes were 1 (11/50; 22%), 23F (8/50; 16%), 14 (6/50; 12%), 5 (5/50; 10%) and 19A (3/50; 6%). Coverage by PCV7, PCV10 and PCV13 was 44%, 76% and 92% respectively. We identified novel multilocus sequence types and resistotypes using whole genome sequencing. CONCLUSIONS: This study suggests IPD is an important disease in Cambodian children and can have a significant mortality. PCV13 coverage of the serotypes determined in studied strains was high and consistent with another recent study. The phenotypic resistance patterns observed were similar to other regional studies. The use of whole genome sequencing in the present study provides additional typing and resistance information together with the description of novel sequence types and resistotypes.

Item Type: Article
Additional Information: Copyright: © 2016 Moore et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Adolescent, Cambodia, Child, Child, Preschool, DNA, Bacterial, Drug Resistance, Bacterial, Female, Genome, Bacterial, Humans, Infant, Infant, Newborn, Male, Phenotype, Pneumococcal Infections, Sequence Analysis, DNA, Serotyping, Streptococcus pneumoniae, Humans, Streptococcus pneumoniae, Pneumococcal Infections, DNA, Bacterial, Serotyping, Sequence Analysis, DNA, Drug Resistance, Bacterial, Phenotype, Genome, Bacterial, Adolescent, Child, Child, Preschool, Infant, Infant, Newborn, Cambodia, Female, Male, General Science & Technology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: PLoS One
ISSN: 1932-6203
Language: eng
Dates:
DateEvent
22 July 2016Published
2 July 2016Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
089275/H/09/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
089275/Z/09/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 27448096
Web of Science ID: WOS:000380799000017
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114481
Publisher's version: https://doi.org/10.1371/journal.pone.0159358

Actions (login required)

Edit Item Edit Item